FCE
BIIB icon

Fiera Capital (Europe)’s Biogen BIIB Stock Holding History

Fiera Capital (Europe)’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-108
Closed -$44K – 55
2015
Q2 		$44K Sell
108
-108
-50% -$43.3K 0.04% 50
2015
Q1 		$92K Sell
216
-448
-67% -$177K 0.08% 45
2014
Q4 		$60K Buy
664
+428
+181% +$138K 0.04% 48
2014
Q3 		$78K Hold
236
– – 0.06% 48
2014
Q2 		$74K Hold
236
– – 0.06% 45
2014
Q1 		$72K Sell
236
-200
-46% -$63.5K 0.05% 42
2013
Q4 		$122K Buy
+436
New +$113K 0.07% 30

Other funds holding BIIB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return

Fiera Capital (Europe)'s BIIB Position: Q3 2015 in Review

Fiera Capital (Europe) sold out of Biogen (BIIB) in Q3 2015, closing a stake of 108 shares — an estimated $44K sold.

Fiera Capital (Europe) first reported a position in BIIB in Q4 2013 and held it in 7 quarters. The position peaked at $122K in Q4 2013. 924 funds tracked by Wall St. Rank hold BIIB as of Q3 2015.

  • Fiera Capital (Europe) reported no remaining Biogen position as of Q3 2015 after selling out during the quarter.
  • Fiera Capital (Europe) sold 108 Biogen shares in Q3 2015, an estimated $44K.
  • Fiera Capital (Europe) first reported a position in Biogen in Q4 2013 and held it in 7 quarters.
  • Fiera Capital (Europe)'s Biogen position peaked at $122K in Q4 2013.
  • 924 funds tracked by Wall St. Rank held Biogen as of Q3 2015.

Based on Fiera Capital (Europe)'s 13F filing for Q3 2015, filed 9 Nov 2015.